At Dipharma, we are honored to receive the “CDMO Solution of the Year in Europe 2025” award from Pharma Tech Outlook Europe.
This recognition reflects our strong commitment to supporting the top-notch pharmaceutical companies in the development and manufacturing of their most complex and innovative products, across every stage of their journey.
To learn more about what sets Dipharma apart, read the exclusive interview with Andrea Confetti, Exclusive Synthesis Business Unit Leader, where he shares insights into Dipharma’s expertise, its dedication to the highest standards of quality and cGMP compliance, and how our flexibility, experience and agility in adapting to changing demands and timelines, help expedite the path to market for smallmolecules in the CDMO industry.
Please read the full article here: Dipharma, Top Drug Discovery and Development Solutions Provider in Europe-2025
Should you require further information about our CDMO experience, feel free to contact us: https://www.dipharma.com/contacts/
For more information
Paola Clerici
Communication Manager
DIPHARMA FRANCIS S.r.l.
paola.clerici@dipharma.com
